[HTML][HTML] EPCAM expression in colon adenocarcinoma and its relationship with TNM staging

M Mokhtari, Z Zakerzade - Advanced biomedical research, 2017 - journals.lww.com
Background: Since epithelial cell adhesion molecule glycoprotein (EPCAM) is associated
with the development and metastasis of colon adenocarcinoma, it can be helpful in …

[HTML][HTML] Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia

IA Mohammed, CJ Streutker, RH Riddell - Modern pathology, 2002 - Elsevier
Long segment Barrett's esophagus (LSBE) is a recognized risk factor for the development of
esophageal dysplasia and carcinoma. However, the risk of dysplasia arising within intestinal …

Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis

S Wang, M Zhan, J Yin, JM Abraham, Y Mori, F Sato… - Oncogene, 2006 - nature.com
To investigate the relationship between Barrett's esophagus (BE) and esophageal
adenocarcinoma (EAC), we determined gene expression profiles of discrete pathological …

Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.

K Washington, A Chiappori, K Hamilton… - Modern pathology: an …, 1998 - europepmc.org
Loss of expression and function of the E-cadherin/catenin membrane complex can result in
loss of cell adhesion and contribute to invasive or metastatic potential in carcinomas. The …

Gene expression alterations in formalin-fixed, paraffin-embedded Barrett esophagus and esophageal adenocarcinoma tissues.

NK Botelho, FI Schneiders, SJ Lord… - Cancer biology & …, 2010 - Taylor & Francis
Background and aim: Widespread applicability of tissue-based mRNA expression screening
for Barrett esophagus (BE) is likely to require (1) accurate methods for assaying archival …

Epithelial Cell Proliferative Activity of Barrett's Esophagus (Methodology and Correlation with Traditional Cancer Risk Markers)

FTM Peters, S Ganesh, EJ Kuipers… - Digestive diseases and …, 1998 - Springer
Barrett's esophagus (BE) is a premalignantcondition, due to chronic gastroesophageal
reflux. Effective antireflux therapy may diminish cancer risk. To evaluate this option an …

[HTML][HTML] Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection

Y Meng, BQ Xu, ZG Fu, B Wu, B Xu… - International Journal of …, 2015 - ncbi.nlm.nih.gov
The identification of reliable prognostic markers that distinguish patients' status and predict
therapeutic response can improve the clinical outcomes of pancreatic cancer patients. The …

Biomarkers in Barrett's esophagus

EM van Lieshout, JB Jansen… - … journal of oncology, 1998 - spandidos-publications.com
Patients with Barrett's esophagus where squamous esophageal epithelium has been
replaced by columnar epithelium containing goblet cells have an increased risk of …

Squamous cellular carcinoma antigen serum determination as a biomarker of Barrett esophagus and esophageal cancer: a Phase III study

G Maddalo, M Fassan, R Cardin… - Journal of Clinical …, 2018 - journals.lww.com
Background: The cost-effectiveness of surveillance in BE is still debated and the use of
biomarkers in screening and surveillance still not recommended. No information is available …

The gene expression profile of cardia intestinal metaplasia is similar to that of Barrett's esophagus, not gastric intestinal metaplasia

DS Oh, SR DeMeester, K Tanaka… - Diseases of the …, 2011 - academic.oup.com
The etiology and significance of cardia intestinal metaplasia (CIM) is disputed. CIM may
represent a form of Barrett's esophagus due to reflux or could reflect generalized gastric …